<DOC>
	<DOCNO>NCT02326961</DOCNO>
	<brief_summary>The primary objective study evaluate safety feasibility intraarticular injection Celution prepare adipose-derived regenerative cell inject knee patient chronic knee pain due osteoarthritis .</brief_summary>
	<brief_title>Celution Prepared Adipose Derived Regenerative Cells Treatment Osteoarthritis Knee</brief_title>
	<detailed_description>The ACT - OA Knee Clinical Trial prospective , randomize , multi-center device trial intend assess safety feasibility intraarticular administration Celution process Adipose Derived Regenerative Cells ( ADRCs ) . The study include 90 patient 15 site United States . Subjects chronic knee pain due idiopathic osteoarthritis knee ( confirm clinically radiologically ) evaluate eligibility study . Following informed consent screen evaluation , eligible subject undergo pre-operative testing . Subjects undergo fat harvest small volume liposuction local anesthesia . Lipoaspirate process Celution System isolate concentrate ADRCs immediate intraarticular administration . A dose escalation approach design wherein study divide two double-blind , randomize , placebo-controlled part follow : Part A : Low Dose ( 20,000,000 cell ) : 30 patient OR Placebo : 15 patient Part B : High Dose ( 40,000,000 cell ) : 30 patient OR Placebo : 15 patient Subjects randomize placebo undergo fat harvest intraarticular injection placebo visually match active test substance . All subject undergo image study , clinical evaluation , laboratory test prior procedure ; patient follow 48 week intraarticular injection perform .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Males females ≥ 40 &lt; 70 year age 2 . Able provide write informed consent 3 . Diagnosis osteoarthritis one knee American College Rheumatology ( ACR ) criteria 4 . Kellgren Lawrence grade 2 3 ( stand AP xray ) target knee within precede 6 month 5 . Pain due osteoarthritis target knee ≥ 6 month 6 . Minimum score `` moderate '' KOOS question pain walk flat surface . 7 . Minimum score `` moderate '' KOOS question degree difficulty walk flat surface . 8 . Continued knee pain limitation knee function despite prescription conservative therapy least 6 month . 9 . Ability safely undergo liposuction result harvest sufficient quantity adipose tissue ( approximately 300 mL ) 10 . On stable regimen one analgesic medication ( rescue medication ) knee pain due osteoarthritis ability willingness use analgesic medication study ( screen period final study visit ) . 11 . Ability perform procedure require pain index evaluation ( unassisted walk 50 foot flat surface go stair ) 1 . Any major injury target knee within 12 month prior screen visit 2 . Need cane assistance device walk 3 . Any surgery target knee within 6 month prior screen visit , surgery contralateral knee weightbearing joint interfere knee assessment 4 . Prior articular transplant procedure 5 . Prior ligament reconstruction target knee within 12 month prior screen visit 6 . Inflammatory arthropathy rheumatoid arthritis , lupus arthropathy , psoriatic arthritis 7 . Gout calcium pyrophosphate ( pseudogout ) diseases flare within previous 6 month prior screen visit 8 . Xray finding acute fracture , know severe loss bone density ( determined investigator ) , avascular necrosis , and/or severe bone joint deformity target knee ( &gt; 5 degree valgus varus deviation mechanical axis ) 9 . Fibromyalgia , pes anserine bursitis , lumbar radiculopathy , and/or neurogenic vascular claudication 10 . Primary knee pain due diagnose isolated patellafemoral arthritis chondromalacia target knee 11 . Significant target knee joint infection skin disorder/infection within previous 6 month prior screen visit 12 . Symptomatic OA hip , spine , ankle , would interfere evaluation target knee 13 . Any condition require immunosuppressive medication use systemic steroid 14 . Intraarticular injection steroid previous 3 month hyaluronic acid previous 6 month one knees prior screening visit 15 . Patients receive PRP , plateletbased product , investigational treatment another cell/biologic study target treatment injury 12 month prior injection procedure 16 . Participation experimental drug device study within 6 month prior screen visit 17 . Obesity define BMI &gt; 35 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>knee</keyword>
	<keyword>adipose derive regenerative cell</keyword>
	<keyword>ADRC</keyword>
	<keyword>Celution</keyword>
	<keyword>arthritis</keyword>
</DOC>